The GC patients had significantly higher concentration of IL-1β, IL-4, IFNγ, and PDGF-BB and lower of IL-1ra, IL-12(p70), IL-13, and MCP-1 than patients with EC or individuals with benign conditions of esophagus and stomach. This evidence concerns the gene CCL2 and gastric cancer.